License: Creative Commons Attribution 4.0 PDF - Published Version (6MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-543843
- DOI to cite this document:
- 10.5283/epub.54384
Abstract
Despite the advancement in drug discovery for cancer therapy, drug repurposing remains an exceptional opportunistic strategy. This approach offers many advantages (faster, safer, and cheaper drugs) typically needed to overcome increased challenges, i.e., side effects, resistance, and costs associated with cancer therapy. However, not all drug classes suit a patient’s condition or long-time use. ...
Owner only: item control page